Literature DB >> 8142069

Effect of disulfiram administration on rat brain glutathione metabolism.

S N Nagendra1, K T Shetty, K M Rao, B S Rao.   

Abstract

Chronic administration of disulfiram (DS) to rats was found to affect glutathione (GSH) metabolism. Glutathione was measured in the rat brain following DS administration. Reduced glutathione was decreased significantly (1.52 +/- 0.3 mumol/g; p < 0.001), with a concomitant increase in oxidised glutathione (GSSG) content (0.12 +/- 0.013 mumol/g; p < 0.001) in the brain as a consequence of DS treatment. However, total glutathione (GSH + GSSG) content of the experimental group did not show any appreciable change. Similar changes were observed in the liver following chronic DS treatment. Brain glutathione reductase (GR) activity was found to be significantly depleted (100 +/- 0.16 mumol/min/mg protein), but glutathione peroxidase (GP) activity was not affected in rats chronically treated with DS. It is reported that the treatment with DS decreases the GSH content, with a concomitant increase in GSSG level, and perturbs the GSH/GSSG redox status, inducing an oxidative stress on the brain. Glutathione reductase implicated in maintaining GSH/GSSG homeostasis by replenishing GSH is also affected by DS potentiating the oxidative damage of the tissue. This effect of DS on glutathione metabolism in the brain would explain some of its known neurotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142069     DOI: 10.1016/0741-8329(94)90004-3

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  4 in total

1.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.

Authors:  A R White; S J Collins; F Maher; M F Jobling; L R Stewart; J M Thyer; K Beyreuther; C L Masters; R Cappai
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Disulfiram lowers Ca2+, Mg(2+)-ATPase activity of rat brain synaptosomes.

Authors:  S N Nagendra; K M Rao; M N Subhash; K T Shetty
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

3.  The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.

Authors:  Juliana Almeida-Silva; Diego Silva Menezes; Juan Mateus Pereira Fernandes; Márcio Cerqueira Almeida; Deyvison Rhuan Vasco-Dos-Santos; Roberto Magalhães Saraiva; Alessandra Lifsitch Viçosa; Sandra Aurora Chavez Perez; Sônia Gumes Andrade; Ana Márcia Suarez-Fontes; Marcos André Vannier-Santos
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

4.  Pharmacological evaluation of disulfiram analogs as antimicrobial agents and their application as inhibitors of fosB-mediated fosfomycin resistance.

Authors:  Alexandria D Lewis; Taylor M Riedel; Meredith B A Kesler; Melinda E Varney; Timothy E Long
Journal:  J Antibiot (Tokyo)       Date:  2022-01-20       Impact factor: 3.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.